DOXYVEK is a first-line therapy for nausea and vomiting of pregnancy. It provides safe and effective symptom control without harming the fetus.
The formulation helps reduce the severity and recurrence of hyperemesis gravidarum. DOXYVEK supports healthy pregnancy outcomes.
Well tolerated for regular use under medical supervision.
Effective management of pregnancy-related nausea and vomiting
First-line therapy for the treatment of nausea and vomiting of pregnancy.
More effective than placebo in controlling nausea and vomiting in pregnant women.
Pre-emptive use helps reduce the recurrence of hyperemesis gravidarum.
Helps prevent pregnancy-related complications and neural tube defects (NTDs).
DOXYVEK works through the combined action of Doxylamine (antiemetic), Pyridoxine (Vitamin B6), and Folic Acid, helping reduce nausea, control vomiting, and support fetal development during pregnancy.
DOXYVEK is recommended for effective control of nausea and vomiting during pregnancy, ensuring better maternal comfort and improved pregnancy outcomes.